18. Spinocerebellar degeneration Clinical trials / Disease details

Clinical trials : 71 / Drugs : 99 - (DrugBank : 30) / Drug target genes : 45 - Drug target pathways : 65

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03888664 (ClinicalTrials.gov)	June 26, 2016	10/3/2019	Open Trail of ?IFN for Friedreich Ataxia	Safety and Efficacy of ?IFN Treatment in Friedreich Ataxia	Friedreich Ataxia	Drug: gamma interferon	IRCCS Eugenio Medea	NULL	Completed	10 Years	40 Years	All	12	Phase 2	NULL
2	NCT02035020 (ClinicalTrials.gov)	May 2013	12/1/2014	A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients	A Phase IIa Clinical Trial to Test the Safety and Efficacy of Interferon Gamma Treatment in Elevating Frataxin Levels in Friedreich's Ataxia (FRDA) Patients	Friedreich Ataxia	Drug: gamma interferon	Azienda Policlinico Umberto I	NULL	Completed	18 Years	45 Years	All	10	Phase 2	Italy